Home › Overweight › Illinois › Arlington Heights
Overweight clinical trials in Arlington Heights, IL
4 studies for Overweight are looking for participants at sites in and around Arlington Heights (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Endeavor Health-Northwest Community Healthcare, Arlington Heights
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
RecruitingPhase 3
- AURORA-1 Clinical Site, Schaumburg · 6 mi away
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, Schaumburg · 6 mi away
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- Knownwell, Schaumburg · 6 mi away
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL28 studies
- Orlando, FL27 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Atlanta, GA20 studies
- Dallas, TX20 studies
- New York City, NY19 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- Austin, TX18 studies
Other studies in Arlington Heights
- Non-Small Cell Lung Cancer12 studies
- Colorectal Cancer12 studies
- Lung Cancer9 studies
- Heart Failure7 studies
- Breast Cancer7 studies
- Metastatic Cancer6 studies
- Ulcerative Colitis6 studies
- Colon Cancer6 studies
- Ovarian Cancer5 studies
- Obesity4 studies
- Cancer (all types)3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.